🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The organization said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also found communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After moments of entering one community, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, posts show black plastic parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to potentially significant medical dangers”.